Compounds > 3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole
Page last updated: 2024-09-03

3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole and epiboxidine

3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole has been researched along with epiboxidine in 1 studies

Compound Research Comparison

Studies
(3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole)		Trials
(3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole)		Recent Studies (post-2010)
(3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole)		Studies
(epiboxidine)		Trials
(epiboxidine)		Recent Studies (post-2010) (epiboxidine)
68218701

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Badio, B; Daly, JW; Garraffo, HM; Padgett, WL; Plummer, CV1

Other Studies

1 other study(ies) available for 3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole and epiboxidine

ArticleYear
Synthesis and nicotinic activity of epiboxidine: an isoxazole analogue of epibatidine.
    European journal of pharmacology, 1997, Feb-26, Volume: 321, Issue:2

    Topics: Animals; Anti-Anxiety Agents; Cerebral Cortex; Ganglia; Isoxazoles; Kinetics; Male; Mice; Nicotine; Nicotinic Agonists; Nociceptors; PC12 Cells; Pyrrolidines; Rats; Receptors, Nicotinic; Tritium

1997